期刊文献+

VHL综合征伴发双侧肾癌个案分析 被引量:15

Case Analysis of Von Hippel - Lindau Syndrome Complicated by Bilateral Renal Cancer
下载PDF
导出
摘要 Von Hippel-Lindau(VHL)综合征为临床十分罕见的家族性常染色体显性遗传性肿瘤综合征,表现为多发、多器官的良、恶性肿瘤征候群,包括中枢神经系统血管母细胞瘤、内脏肿瘤和囊肿等。发病率约1/3.6万,平均发病年龄为26.3~30.9岁。预后不良,平均生存年龄<49岁,其主要死亡原因是中枢神经系统血管母细胞瘤破裂出血、肾细胞癌和嗜铬细胞引起的恶性高血压。现介绍1例经浙江湖州师范学院附属第一医院泌尿外科收治的中枢神经系统血管母细胞瘤伴发双侧肾癌,附睾、肝、胰腺多发囊肿病例。该患者经左侧保留肾单位的肾癌切除术,索尼替尼分子靶向治疗后效果较佳,随访30个月,生存良好。 Objectives: Von Hippel - Lindau disease is a rare, autosomal dominant neoplastic syndrome characterized by multiple benign and malignant tumors that affect multiple organs, including the central nervous system ( CNS ) hemangioblastomas, visceral tumor, and cysts. The average age of onset ofVon Hippel - Lindau disease is between 26.3 years old and 30.9 years old, with an incidence rate of 1 : 36 000. This disease has a poor prognosis, and the average life expectancy is below 49 years old. The main causes of death is usually rupture and bleeding of CNS hemangioblastomas, renal cell carcinoma, and malignant hypertension caused by pheochromocytoma. We present a case ofVon Hippel - Lindau disease with CNS hemangioblastoma, complicated by bilateral renal cancer, and multiple cysts in the epididymis, liver, and pancreas in the First Affiliated Hospital of Huzhou Teachers College. The patient underwent nephron - sparing surgery of the left kidney and he was given sunitinib malate as molecule - targeted therapy. Patient followed-up consistently for 30 months, and the patient survived and is living well.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2012年第16期1229-1232,共4页 Chinese Journal of Clinical Oncology
关键词 VHL综合症 泌尿系统 中枢神经系统血管母细胞瘤 肾肿瘤 Von Hippel - Lindau disease Urinary system Central nervous system hemangioblastoma Renal tumor
  • 相关文献

参考文献12

二级参考文献41

  • 1张军军,严密,夏瑞南,蔡如超.von Hippel-Lindau病伴双眼眼内骨化一例[J].中华眼底病杂志,1994,10(1):40-41. 被引量:3
  • 2Choyke PL, Glenn GM, Walther MM, et al. von- Hippel-Lindau disease., genetic, clinical, and imaging features[J]. Radiology, 1995, 194: 629-642.
  • 3Melmon KI, Rosen SW. Lindau disease. Review of literature and study of a large kindred[J]. Am J Med, 1964, 36(2): 595- 617.
  • 4Latif F, Tory K, Gnarra JR, et al. Identification of the yon Hippel-Lindau disease tumor suppressor gene [J]. Science, 1993, 260(5 112): 1317-1320.
  • 5Miller DL, Choyke PL, Walther MM, et al. vonHipp el-Lindau disease., inadequacy of angiography for identi fication of renal cancers[J]. Radiology, 1991, 179(3):833-836.
  • 6Lonser RR, Glenn GM, Walther M, et al. von Hippel- Lindau disease [J]. Lancet, 2003, 361 (9374) : 2059- 2067.
  • 7Marcos HB, Libutti SK, Alexander HR, et al. Neuroendocrine tumors of the pancreas in yon Hippel-Lindau disease: spectrum of appearances at CT and MR imaging with histopathologic comparison [J]. Radiology, 2002, 225:751-757.
  • 8Kluetz PG, Meltzer CC, Villemagne VL, et al. Combined PET/CT imaging in ontology: impact on patient management [J]. Clin Pos Imag, 2000, 3(6): 223- 230.
  • 9Glasker S. Central nervous system manifestations in VHL: genetics, pathology and clinical phenotypic features[J]. FamCancer, 2005, 4(1): 37-42.
  • 10Maher ER, Yates JR, Harrles R, et al. Clinical feature and natural history of yon Hippel-Lindau disease [J]. QuarterlyJ Med, 1990, 77:1151-1163.

共引文献13

同被引文献61

引证文献15

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部